Sumatriptan Nasal Spray for Acute Migraine
A multicenter, randomized, double-blind, placebo-controlled trial of sumatriptan nasal spray (5 mg, 10 mg, and 20 mg) was conducted in 653 adolescents presenting with acute migraine at the Palm Beach Headache Center, Florida; Cleveland Clinic, OH; Michigan Headache Institute, Ann Arbor; and San Anto...
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2000-11-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/1841 |
Similar Items
-
Cranial Autonomic Symptoms in Migraine
by: J Gordon Millichap
Published: (2009-11-01) -
Sumatriptan Nasal Spray for Acute Migraine
by: J Gordon Millichap
Published: (1997-12-01) -
Juvenile Idiopathic Stabbing Headache
by: J Gordon Millichap
Published: (1996-12-01) -
Migraine Associated Symptom Prevalence
by: J Gordon Millichap
Published: (1995-08-01) -
‘Visual Snow’ - Distinct from Migraine Aura
by: J Gordon Millichap, et al.
Published: (2014-06-01)